Clinical trials recruiting for Carcinoma, Squamous Cell
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| BCA101 | 1 |
| N17350 | 1 |
| Nicotinamide | 1 |
| Osimertinib | 1 |
| Pembrolizumab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| New York | 2 |
| Texas | 2 |
| Florida | 1 |
| Massachusetts | 1 |
| North Carolina | 1 |
| Ohio | 1 |
| Pennsylvania | 1 |
| Rhode Island | 1 |
| South Carolina | 1 |
| Tennessee | 1 |
Top cities
Self-screener
Recruiting trials
- Intratumoral N17350 in Advanced Solid Tumors
- Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma
- Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial
- Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Related conditions
Trials recruiting for Carcinoma, Squamous Cell often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Carcinoma, Squamous Cell trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.